Onward Therapeutics SA (Onward Therapeutics) and Emercell SAS (Emercell) announced the recent exercise of Onward Therapeutics' second of three instalments of equity investment in...
Moleculin Biotech, Inc., a clinical stage pharmaceutical company with a broad portfolio of drug candidates targeting highly resistant tumors and viruses, reported preliminary results...
Cizzle Biotechnology Holdings PLC, the UK based diagnostics developer, is pleased to announce that it has entered into an agreement with the Behnke Group,...
Nonagen Bioscience, a cancer diagnostics company, announced CE marking for its Oncuria immunoassay for bladder cancer.
Oncuria is the first-of-its-kind multiplex urine test for the...
Frost & Sullivan's recent analysis, Global Pharmaceuticals Outlook, finds that the accelerated drug development timelines are driving digitalization and innovation across the pharmaceutical value...
